The review process

The Scientific Steering Committee for the innovation grant comprises internationally renowned experts in the field and representatives from EMD Serono Oncology. The Committee undertakes a rigorous process of review and assessment of eligible projects before validating its selection of grant awardees.

The names of the applicants and their institutions are completely blinded to the members of the Scientific Steering Committee to keep the scientific merit of the proposals as the key criteria for selection. All proposals are rated from 1 to 5 (with 5 being the highest) against each of the following criteria:

  • Relevance to patient care
  • Innovative approach
  • Scientific impact
  • Feasibility
  • Relevance for the personalization of treatment

A final score is then calculated and the projects ranked accordingly. After each round of selection, the GOI secretariat will contact successful applicants individually to inform them of the status of their application and, if necessary, request additional information.

All projects that pass to the second round of review will have to submit the formal project protocol, budget, and a signed document that confirms their acceptance of the grant rules and regulations for advanced applications. Based on this information, the Scientific Steering Committee will make their final acceptance decisions.

How is the awarding of the grant formalized?

The grant recipient will enter into a written agreement with EMD Serono, which documents the conditions of the grant and the further collaboration between EMD Serono and the awardee(s).

What about publicity?

EMD Serono retains the exclusive right to make any press release or any kind of public communication about the Grant for Oncology Innovation, the grants, and the Awardees.

What happens to applications and other submitted documents?

EMD Serono, Inc. (Merck KGaA, Darmstadt, Germany) treats all submissions confidentially. As per the default rule of the Document Retention Policy of Merck KGaA, Darmstadt, Germany, all major Grant for Oncology Innovation documents are archived for a period of 10 years.

Data Protection Information

By submitting the information requested in the letter of intent, you understand and agree that EMD Serono may share personally identifiable data about you with outside companies or agents working on our behalf, as well as company's subsidiaries and affiliates, to help process the submissions. All these companies and agents are required to comply with the terms of our privacy policies. Some of this data may be stored or processed on computers located in other jurisdictions, such as the United States, whose data protection laws may differ from those in the jurisdiction in which you live. In such cases, we will ensure that appropriate protections are in place to require the data processor in that country to maintain protections on the data that are equivalent to those that apply in Germany.